UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A phase III study of belagenpumatucel-L, an allogeneic tumour cell vaccine, as maintenance therapy for non-small cell lung cancer

European journal of cancer (1990), 2015-11, Vol.51 (16), p.2321-2329

2015

Volltextzugriff (PDF)

Timing of treatment in small cell lung cancer

Annals of oncology, 2018-10, Vol.29, p.viii598-viii598

2018

Volltextzugriff (PDF)

Pooled preventable death rates in trauma patients: Meta analysis and systematic review since 1990

European journal of trauma and emergency surgery (Munich : 2007), 2014-06, Vol.40 (3), p.279-285

2014

Volltextzugriff (PDF)

MO01.26 Second Primary Lung Cancer with NTRK1 mutation after Initial Primary mEGFR Lung Cancer

Journal of thoracic oncology, 2021-01, Vol.16 (1), p.S26-S26

2021

Volltextzugriff (PDF)

Patient perceptions concerning clinical trials in oncology patients

Contemporary clinical trials communications, 2016-12, Vol.4 (C), p.179-185

2016

Volltextzugriff (PDF)

Evaluation of Prognostic Variables in Patients With Small Cell Lung Cancer: The Role of Volumetric Response to Initial Therapy in Determining the Benefit of Prophylactic Cranial Irradiation

International journal of radiation oncology, biology, physics, 2014-11, Vol.90 (5), p.S65-S65

2014

Volltextzugriff (PDF)

Evaluation of Prognostic Variables in Patients With Small Cell Lung Cancer: The Role of Volumetric Response to Initial Therapy in Determining the Benefit of Prophylactic Cranial Irradiation

International journal of radiation oncology, biology, physics, 2014-09, Vol.90 (1), p.S633-S633

2014

Volltextzugriff (PDF)

PD1.02 Non-Small Cell Lung Cancer in the US Hispanic Population: A National Cancer Database Analysis

Journal of thoracic oncology, 2019-11, Vol.14 (11), p.S1167-S1167

2019

Volltextzugriff (PDF)

CP01.03 COVID 19’s Pandemic’s Effect on a Community Lung Cancer Screening Program

Journal of thoracic oncology, 2021-01, Vol.16 (1), p.S13-S13

2021

Volltextzugriff (PDF)

1670PTiming of treatment in small cell lung cancer

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

P1.15-23 Factors Affecting Treatment in Non-Small Cell Lung Cancer Patients

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S621-S621

2018

Volltextzugriff (PDF)

P1.15-02 Migration Differences in Small Cell vs Non-Small Cell Lung Cancer

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S611-S611

2018

Volltextzugriff (PDF)

Tumor Treating Fields (TTFields) Therapy with Standard of Care in Metastatic Non-small Cell Lung Cancer Following Progression on or after Platinum Therapy: Global, Randomized, Pivotal Phase 3 LUNAR Study

International journal of radiation oncology, biology, physics, 2024-01, Vol.118 (1), p.e9-e10

2024

Volltextzugriff (PDF)

1418P Impact of TTFields therapy on global and functional health-related quality of life (HRQoL) in metastatic non-small cell lung cancer (mNSCLC) from the pivotal LUNAR study

Annals of oncology, 2023-10, Vol.34, p.S810-S810

2023

Volltextzugriff (PDF)

OA22.05 TTFields and Immune-Checkpoint Inhibitor in Metastatic Non-Small Cell Lung Cancer: PD-L1 Subgroups in the Phase 3 LUNAR Study

Journal of thoracic oncology, 2023-11, Vol.18 (11), p.S96-S97

2023

Volltextzugriff (PDF)

P2.01-23 DUBLIN-3, a Phase (Ph) III Trial Comparing the Plinabulin (P)/Docetaxel(D) Combination with D Alone in Stage IIIb/IV NSCLC

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S647-S648

2019

Volltextzugriff (PDF)

Urinary incontinence among male veterans receiving care in primary care clinics

Annals of internal medicine, 2000-04, Vol.132 (7), p.547

2000

Volltextzugriff (PDF)

OA07.03 A Phase II Study of Frontline Rucaparib + Nivolumab in Platinum Sensitive ES SCLC: Interim Analysis

Journal of thoracic oncology, 2021-10, Vol.16 (10), p.S859-S859

2021

Volltextzugriff (PDF)

4B.01 Lung Cancer Patients Migrate to Seek Better Care

Journal of thoracic oncology, 2017-11, Vol.12 (11), p.S1559-S1560

2017

Volltextzugriff (PDF)

4B.01 Lung Cancer Patients Migrate to Seek Better Care: Topic: Medical Oncology

Journal of thoracic oncology, 2017-11, Vol.12 (11), p.S1559-S1560

2017

Volltextzugriff (PDF)

Carbon Nanotube Devices for the Detection Of Circulating Tumor Cells

Annals of oncology, 2012-09, Vol.23, p.ix87

2012

Volltextzugriff (PDF)

Associations between the prognostic indicators rest/activity rhythm and diurnal cortisol profiles in patients with lung cancer

Brain, behavior, and immunity, 2017-11, Vol.66, p.e31-e32

2017

Volltextzugriff (PDF)

OA01.07 Updated Results of a Phase II Trial of Concurrent Chemoradiation with Consolidation Pembrolizumab in Patients with Unresectable Stage III NSCLC

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S321-S321

2018

Volltextzugriff (PDF)

P1.18-05 ChemoXRT W/ Consolidation Pembrolizumab in Unresectable Stage III NSCLC: Long-Term Survival Update and Analysis of Post-Progression Therapy

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S627-S627

2019

Volltextzugriff (PDF)

TTFields (Tumor Treating Fields) associés au traitement standard dans les cancers du poumon non à petites cellules métastatiques en progression après platine : étude internationale, randomisée de phase 3 LUNAR

Revue des maladies respiratoires actualités, 2024-01, Vol.16 (1), p.269-270

2024

Volltextzugriff (PDF)

1 – 25 von 159

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(83)
Mit Volltextzugriff
(147)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A phase III study of belagenpumatucel-L, an allogeneic tumour cell vaccine, as maintenance therapy for non-small cell lung cancer

Timing of treatment in small cell lung cancer

Pooled preventable death rates in trauma patients: Meta analysis and systematic review since 1990

MO01.26 Second Primary Lung Cancer with NTRK1 mutation after Initial Primary mEGFR Lung Cancer

Patient perceptions concerning clinical trials in oncology patients

Evaluation of Prognostic Variables in Patients With Small Cell Lung Cancer: The Role of Volumetric Response to Initial Therapy in Determining the Benefit of Prophylactic Cranial Irradiation

Evaluation of Prognostic Variables in Patients With Small Cell Lung Cancer: The Role of Volumetric Response to Initial Therapy in Determining the Benefit of Prophylactic Cranial Irradiation

PD1.02 Non-Small Cell Lung Cancer in the US Hispanic Population: A National Cancer Database Analysis

CP01.03 COVID 19’s Pandemic’s Effect on a Community Lung Cancer Screening Program

1670PTiming of treatment in small cell lung cancer

P1.15-23 Factors Affecting Treatment in Non-Small Cell Lung Cancer Patients

P1.15-02 Migration Differences in Small Cell vs Non-Small Cell Lung Cancer

Tumor Treating Fields (TTFields) Therapy with Standard of Care in Metastatic Non-small Cell Lung Cancer Following Progression on or after Platinum Therapy: Global, Randomized, Pivotal Phase 3 LUNAR Study

1418P Impact of TTFields therapy on global and functional health-related quality of life (HRQoL) in metastatic non-small cell lung cancer (mNSCLC) from the pivotal LUNAR study

OA22.05 TTFields and Immune-Checkpoint Inhibitor in Metastatic Non-Small Cell Lung Cancer: PD-L1 Subgroups in the Phase 3 LUNAR Study

P2.01-23 DUBLIN-3, a Phase (Ph) III Trial Comparing the Plinabulin (P)/Docetaxel(D) Combination with D Alone in Stage IIIb/IV NSCLC

Urinary incontinence among male veterans receiving care in primary care clinics

OA07.03 A Phase II Study of Frontline Rucaparib + Nivolumab in Platinum Sensitive ES SCLC: Interim Analysis

4B.01 Lung Cancer Patients Migrate to Seek Better Care

4B.01 Lung Cancer Patients Migrate to Seek Better Care: Topic: Medical Oncology

Carbon Nanotube Devices for the Detection Of Circulating Tumor Cells

Associations between the prognostic indicators rest/activity rhythm and diurnal cortisol profiles in patients with lung cancer

OA01.07 Updated Results of a Phase II Trial of Concurrent Chemoradiation with Consolidation Pembrolizumab in Patients with Unresectable Stage III NSCLC

P1.18-05 ChemoXRT W/ Consolidation Pembrolizumab in Unresectable Stage III NSCLC: Long-Term Survival Update and Analysis of Post-Progression Therapy

TTFields (Tumor Treating Fields) associés au traitement standard dans les cancers du poumon non à petites cellules métastatiques en progression après platine : étude internationale, randomisée de phase 3 LUNAR

Suchergebnisse filtern